It cannot regrow hair in fully dead follicles and works best as an adjunct to FDA-approved treatments
FDA-studied growth hormone-releasing hormone (GHRH) analog specifically shown to reduce visceral abdominal fat
Some cold medicines contain similar ingredients, which can increase side effects
In rat studies, BPC-157 demonstrated healing effects in various colitis models, including cysteamine-induced colitis, improved intestinal anastomosis healing, and promoted closure of gastrointestinal fistulascomplications relevant to Crohn's disease.[4][5][3] The proposed mechanisms include interaction with the nitric oxide system, angiogenic effects, endothelium protection, and modulation of growth factor expression.[1][6] Critical limitations include the lack of published results from controlled human trials, absence of FDA approval, and concerns about products being sold online without regulatory oversight.[2] The peptide was temporarily banned by the World Anti-Doping Agency in 2022, though it is not currently listed as banned.[2] Given these limitations, BPC-157 cannot be recommended as standard therapy for ulcerative colitis or Crohn's disease based on current evidence
Qiao, L
Convenient and Pain-Free: Easy-to-use spray eliminates the need for invasive treatments
